These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27689322)

  • 1. Case-specific potentiation of glioblastoma drugs by pterostilbene.
    Schmidt L; Baskaran S; Johansson P; Padhan N; Matuszewski D; Green LC; Elfineh L; Wee S; Häggblad M; Martens U; Westermark B; Forsberg-Nilsson K; Uhrbom L; Claesson-Welsh L; Andäng M; Sintorn IM; Lundgren B; Lönnstedt I; Krona C; Nelander S
    Oncotarget; 2016 Nov; 7(45):73200-73215. PubMed ID: 27689322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapy.
    Joshi AD; Loilome W; Siu IM; Tyler B; Gallia GL; Riggins GJ
    PLoS One; 2012; 7(10):e44372. PubMed ID: 23056179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic interactions between camptothecin and EGFR or RAC1 inhibitors and between imatinib and Notch signaling or RAC1 inhibitors in glioblastoma cell lines.
    Sooman L; Ekman S; Andersson C; Kultima HG; Isaksson A; Johansson F; Bergqvist M; Blomquist E; Lennartsson J; Gullbo J
    Cancer Chemother Pharmacol; 2013 Aug; 72(2):329-40. PubMed ID: 23736154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ROS1 amplification mediates resistance to gefitinib in glioblastoma cells.
    Aljohani H; Koncar RF; Zarzour A; Park BS; Lee SH; Bahassi el M
    Oncotarget; 2015 Aug; 6(24):20388-95. PubMed ID: 25978031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis.
    Yang YP; Chang YL; Huang PI; Chiou GY; Tseng LM; Chiou SH; Chen MH; Chen MT; Shih YH; Chang CH; Hsu CC; Ma HI; Wang CT; Tsai LL; Yu CC; Chang CJ
    J Cell Physiol; 2012 Mar; 227(3):976-93. PubMed ID: 21503893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
    Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
    Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Elemene enhances the efficacy of gefitinib on glioblastoma multiforme cells through the inhibition of the EGFR signaling pathway.
    Mu L; Wang T; Chen Y; Tang X; Yuan Y; Zhao Y
    Int J Oncol; 2016 Oct; 49(4):1427-36. PubMed ID: 27498706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative drug pair screening across multiple glioblastoma cell lines reveals novel drug-drug interactions.
    Schmidt L; Kling T; Monsefi N; Olsson M; Hansson C; Baskaran S; Lundgren B; Martens U; Häggblad M; Westermark B; Forsberg Nilsson K; Uhrbom L; Karlsson-Lindahl L; Gerlee P; Nelander S
    Neuro Oncol; 2013 Nov; 15(11):1469-78. PubMed ID: 24101737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells.
    Atif F; Patel NR; Yousuf S; Stein DG
    PLoS One; 2015; 10(6):e0131441. PubMed ID: 26110872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pterostilbene, a natural phenolic compound, synergizes the antineoplastic effects of megestrol acetate in endometrial cancer.
    Wen W; Lowe G; Roberts CM; Finlay J; Han ES; Glackin CA; Dellinger TH
    Sci Rep; 2017 Oct; 7(1):12754. PubMed ID: 28986550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment.
    Cenciarelli C; Marei HE; Zonfrillo M; Pierimarchi P; Paldino E; Casalbore P; Felsani A; Vescovi AL; Maira G; Mangiola A
    Mol Cancer; 2014 Nov; 13():247. PubMed ID: 25380967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence, Bioavailability, Anti-inflammatory, and Anticancer Effects of Pterostilbene.
    Lin WS; Leland JV; Ho CT; Pan MH
    J Agric Food Chem; 2020 Nov; 68(46):12788-12799. PubMed ID: 32064876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pterostilbene, a natural analogue of resveratrol, potently inhibits 7,12-dimethylbenz[a]anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA)-induced mouse skin carcinogenesis.
    Tsai ML; Lai CS; Chang YH; Chen WJ; Ho CT; Pan MH
    Food Funct; 2012 Nov; 3(11):1185-94. PubMed ID: 22842666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATM/CHK/p53 Pathway Dependent Chemopreventive and Therapeutic Activity on Lung Cancer by Pterostilbene.
    Lee H; Kim Y; Jeong JH; Ryu JH; Kim WY
    PLoS One; 2016; 11(9):e0162335. PubMed ID: 27612029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatment of AT101 and demethoxycurcumin yields an enhanced anti-proliferative effect in human primary glioblastoma cells.
    Mehner M; Kubelt C; Adamski V; Schmitt C; Synowitz M; Held-Feindt J
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):117-126. PubMed ID: 31844979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pterostilbene induces apoptosis and cell cycle arrest in human gastric carcinoma cells.
    Pan MH; Chang YH; Badmaev V; Nagabhushanam K; Ho CT
    J Agric Food Chem; 2007 Sep; 55(19):7777-85. PubMed ID: 17696482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of F90, an epidermal growth factor receptor tyrosine kinase inhibitor, on glioblastoma cell line SHG-44.
    Liu FJ; Gui SB; Li CZ; Sun ZL; Zhang YZ
    Chin Med J (Engl); 2008 Sep; 121(17):1702-6. PubMed ID: 19024103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Anticancer Activity of Pterostilbene Against Three Subtypes of Human Breast Cancer Cells.
    Wakimoto R; Ono M; Takeshima M; Higuchi T; Nakano S
    Anticancer Res; 2017 Nov; 37(11):6153-6159. PubMed ID: 29061796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pterostilbene inhibits breast cancer in vitro through mitochondrial depolarization and induction of caspase-dependent apoptosis.
    Alosi JA; McDonald DE; Schneider JS; Privette AR; McFadden DW
    J Surg Res; 2010 Jun; 161(2):195-201. PubMed ID: 20031172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen in combination with temozolomide induce a synergistic inhibition of PKC-pan in GBM cell lines.
    Balça-Silva J; Matias D; do Carmo A; Girão H; Moura-Neto V; Sarmento-Ribeiro AB; Lopes MC
    Biochim Biophys Acta; 2015 Apr; 1850(4):722-32. PubMed ID: 25554223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.